Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-05-05 @ 4:56 AM
Study NCT ID:
NCT00780494
Status:
COMPLETED
Last Update Posted:
2025-01-14
First Post:
2008-10-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
Sponsor:
Stanford University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IRB-11911
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |